Jaguar Health (NASDAQ:JAGX) Shares Gap Down to $7.69

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) gapped down prior to trading on Thursday . The stock had previously closed at $7.69, but opened at $7.02. Jaguar Health shares last traded at $5.94, with a volume of 295,622 shares trading hands.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Jaguar Health in a report on Friday. They set a “sell” rating on the stock.

Jaguar Health Stock Down 9.7 %

The company has a current ratio of 1.89, a quick ratio of 1.39 and a debt-to-equity ratio of 1.84. The company’s fifty day moving average price is $9.61 and its 200-day moving average price is $9.94.

Jaguar Health (NASDAQ:JAGX) last announced its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($3.60) earnings per share for the quarter. Jaguar Health had a negative net margin of 377.95% and a negative return on equity of 642.15%. The firm had revenue of $2.35 million for the quarter. Sell-side analysts predict that Jaguar Health, Inc. will post -5.42 EPS for the current year.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.